We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Nordic Bioscience Biomarker Assay Shows Promise in Heart Failure Patients in Study
Nordic Bioscience Biomarker Assay Shows Promise in Heart Failure Patients in Study
New research published in the NEJM Evidence shows potential for Nordic Bioscience’s PRO-C6 assay becoming a next-generation biomarker in trials studying patients with heart failure with preserved ejection fraction (HFpEF).